Pedro Cano

2.3k total citations
56 papers, 1.4k citations indexed

About

Pedro Cano is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Pedro Cano has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 24 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Pedro Cano's work include Hematopoietic Stem Cell Transplantation (20 papers), T-cell and B-cell Immunology (16 papers) and Renal Transplantation Outcomes and Treatments (7 papers). Pedro Cano is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), T-cell and B-cell Immunology (16 papers) and Renal Transplantation Outcomes and Treatments (7 papers). Pedro Cano collaborates with scholars based in United States, Canada and Lebanon. Pedro Cano's co-authors include Marcelo Fernández-Viña, Richard E. Champlin, Marcos de Lima, Elizabeth J. Shpall, Sergio Giralt, Stefan O. Ciurea, Jerry Li, Xuemei Wang, Peter F. Thall and Martin Körbling and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Pedro Cano

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro Cano United States 19 806 740 301 159 155 56 1.4k
Yamin Tan China 18 580 0.7× 332 0.4× 74 0.2× 165 1.0× 152 1.0× 83 971
Giuseppe Morreale Italy 20 365 0.5× 385 0.5× 96 0.3× 290 1.8× 79 0.5× 53 1.2k
Sonia Bonanomi Italy 16 360 0.4× 328 0.4× 142 0.5× 233 1.5× 117 0.8× 45 820
Ernesto Ayala United States 20 717 0.9× 348 0.5× 95 0.3× 552 3.5× 227 1.5× 140 1.5k
NK Ramsay United States 18 1.3k 1.6× 470 0.6× 76 0.3× 379 2.4× 239 1.5× 37 1.7k
David Michonneau France 20 439 0.5× 421 0.6× 55 0.2× 268 1.7× 75 0.5× 82 1.2k
Jill Moss United Kingdom 17 236 0.3× 763 1.0× 64 0.2× 75 0.5× 74 0.5× 35 1.3k
Yasushi Fuchimoto Japan 20 228 0.3× 276 0.4× 311 1.0× 129 0.8× 67 0.4× 82 1.5k
Yngvar Fløisand Norway 20 520 0.6× 513 0.7× 32 0.1× 189 1.2× 87 0.6× 77 1.2k
Elizabeth Rich United States 17 681 0.8× 451 0.6× 45 0.1× 556 3.5× 183 1.2× 56 1.2k

Countries citing papers authored by Pedro Cano

Since Specialization
Citations

This map shows the geographic impact of Pedro Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Cano more than expected).

Fields of papers citing papers by Pedro Cano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Cano. The network helps show where Pedro Cano may publish in the future.

Co-authorship network of co-authors of Pedro Cano

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Cano. A scholar is included among the top collaborators of Pedro Cano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Cano. Pedro Cano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alontaga, Aileen Y., Pedro Cano, John Puskas, et al.. (2024). Implementation of a High-Accuracy Targeted Gene Expression Panel for Clinical Care. Journal of Molecular Diagnostics. 26(8). 685–699. 2 indexed citations
2.
Alontaga, Aileen Y., Pedro Cano, John M. Koomen, et al.. (2024). Unveiling the Molecular Features of SCLC With a Clinical RNA Expression Panel. JTO Clinical and Research Reports. 5(11). 100723–100723. 1 indexed citations
3.
Ciurea, Stefan O., Peter F. Thall, Xuemei Wang, et al.. (2011). Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood. 118(22). 5957–5964. 148 indexed citations
4.
Bernatchez, Chantale, Kuichun Zhu, Yufeng Li, et al.. (2011). Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals. Vaccine. 29(16). 3021–3030. 10 indexed citations
5.
Bade‐Doeding, Christina, Pedro Cano, Trevor Huyton, et al.. (2011). 27-OR Mismatches outside exon 2 and 3 do not alter the function of the allele group B*44:02p. Human Immunology. 72. S172–S172. 2 indexed citations
6.
7.
Ciurea, Stefan O., Marcos de Lima, Pedro Cano, et al.. (2009). High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem-Cell Transplantation. Transplantation. 88(8). 1019–1024. 184 indexed citations
8.
Cano, Pedro & Marcelo Fernández-Viña. (2009). Two sequence dimorphisms of DPB1 define the immunodominant serologic epitopes of HLA-DP. Human Immunology. 70(10). 836–843. 32 indexed citations
9.
Ciurea, Stefan O., Rima M. Saliba, Gabriela Rondón, et al.. (2009). Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. Bone Marrow Transplantation. 45(3). 429–436. 42 indexed citations
10.
Cano, Pedro, William Klitz, Steven J. Mack, et al.. (2007). Common and Well-Documented HLA Alleles. Human Immunology. 68(5). 392–417. 170 indexed citations
11.
Vaidya, Smita, et al.. (2007). DP reactive antibody in a zero mismatch renal transplant pair. Human Immunology. 68(12). 947–949. 29 indexed citations
12.
Zhu, Kuichun, Gregory Lizée, Pedro Cano, et al.. (2006). HLA-A0201 positive pancreatic cell lines: new findings and discrepancies. Cancer Immunology Immunotherapy. 56(5). 719–724. 2 indexed citations
13.
Luthra, Rajyalakshmi, et al.. (2004). Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11). BMC Cancer. 4(1). 25–25. 20 indexed citations
14.
Cano, Pedro, et al.. (2003). Effect of Polymeric Diets in Patients on Continuous Ambulatory Peritoneal Dialysis. Peritoneal Dialysis International. 23(5). 434–439. 9 indexed citations
15.
Cano, Pedro & Bo Fan. (2001). A geometric and algebraic view of MHC-peptide complexes and their binding properties. BMC Structural Biology. 1(1). 2–2. 6 indexed citations
16.
Cano, Pedro, Bo Fan, & Sanford A. Stass. (1998). A geometric study of the amino acid sequence of class I HLA molecules. Immunogenetics. 48(5). 324–334. 18 indexed citations
17.
DeChristopher, Phillip J., et al.. (1995). Peripheral blood stem cell collection with reduced platelet loss to the patient/donor. Journal of Clinical Apheresis. 10(1). 1–6. 4 indexed citations
18.
Cano, Pedro & Lee Ann Baxter‐Lowe. (1995). Novel human TAP2*103 allele shows further polymorphism in the ATP‐binding domain. Tissue Antigens. 45(2). 139–142. 18 indexed citations
19.
Bonnyns, M., Pedro Cano, C. Kirk Osterland, & J. M. McKenzie. (1978). Immune reactions in patients with Graves' disease. The American Journal of Medicine. 65(6). 971–977. 8 indexed citations
20.
Cano, Pedro, et al.. (1976). Circuiating Immune Complexes in Graves’ Disease. Endocrine Research Communications. 3(5). 307–317. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026